top of page
Starting August 1, 2024, Quickarrays Inc. will be taking over Pantomics Inc. to
provide all products and services. Please visit Quickarrays Inc. for more information.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
Hermatopathology
EMC962
Endometrial cancer tissue array, set 2, non-overlapping with EMC962, 96 cores, 48 cases from normal, premalignant and cancer tissues with progressive grades and TNM stages in duplicates.
Specification
Data Sheet
TNM Grading
Downloads
Price
Size
Availability
$289
1 slide
In-Stock
A | |
B | |
C | |
D | |
E | |
F | |
G | |
H | |
TNM Classification : Endometrium carcinoma
T- Primary tumor
TX - Primary tumor cannot be assessed
TO - No evidence of primary tumor
Tis - Carcinoma in situ (preinvasive carcinoma)
T1 - Tumor confined to corpus uteri
T1a - Tumor limited to endometrium
T1 b - Tumor invades up to less than one half of myometrium
T1c - Tumor invades to more than one half of myometrium
T2 - Tumor invades cervix but does not extend beyond uterus
T2a - Endocervical glandular involvement only
T2b - Cervical stromal invasion
T3 (and/or N1) - Local or regional spread as specified below
T3a - Tumor invlove serosa and/or adnexa and/or cancer cells in ascites or peritoneal washing
T3b - Vaginal involvement
(N1) - Metastasis to pelvic and/or para-aortic lymph nodes
T4 - Tumor invades bladder mucosa and/or bowel mucosa
N - Regional lymph nodes
NX - Regional lymph nodes cannot be assessed
NO - No regional lymph node metastasis N1 - Regional lymph node metastasis
N1a - Metastasis in a single regional lymph node
N1b - Metastasis in multiple regional lymph nodes
M - Distant metastasis
MX - Distant metastasis cannot be assessed
MO - No distant metastasis
M1 - Distant metastasis
Human
48
96
1.5mm
4um
8
12
Paraffin
Notes:
All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.
Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in evolution and progression of endometrium cancers.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|
A01 | F | 44 | Uterus, endometrium | Normal | |||
A02 | F | 37 | Uterus, endometrium | Normal | |||
A03 | F | 40 | Uterus, endometrium | Normal | |||
A04 | F | 45 | Uterus, endometrium | Endometrium of proliferative phase | |||
A05 | F | 49 | Uterus, endometrium | Endometrium of proliferative phase | |||
A06 | F | 72 | Uterus, endometrium | Endometrium of proliferative phase | |||
A07 | F | 34 | Uterus, endometrium | Endometrium of proliferative phase | |||
A08 | F | 56 | Uterus, endometrium | Simple hyperplasia | |||
A09 | F | 47 | Uterus, endometrium | Simple hyperplasia | |||
A10 | F | 40 | Uterus, endometrium | Endometrium | |||
A11 | F | 52 | Uterus, endometrium | Endometrium | |||
A12 | F | 40 | Uterus, endometrium | Polyps | |||
B01 | F | 44 | Uterus, endometrium | Normal | |||
B02 | F | 37 | Uterus, endometrium | Normal | |||
B03 | F | 40 | Uterus, endometrium | Normal | |||
B04 | F | 45 | Uterus, endometrium | Endometrium of proliferative phase | |||
B05 | F | 49 | Uterus, endometrium | Endometrium of proliferative phase | |||
B06 | F | 72 | Uterus, endometrium | Endometrium of proliferative phase | |||
B07 | F | 34 | Uterus, endometrium | Endometrium of proliferative phase | |||
B08 | F | 56 | Uterus, endometrium | Simple hyperplasia | |||
B09 | F | 47 | Uterus, endometrium | Simple hyperplasia | |||
B10 | F | 40 | Uterus, endometrium | Endometrium | |||
B11 | F | 52 | Uterus, endometrium | Endometrium | |||
B12 | F | 40 | Uterus, endometrium | Polyps | |||
C01 | F | 43 | Uterus, endometrium | Adenocarcinoma | I | T1N0M0 | |
C02 | F | 39 | Uterus, endometrium | Adenocarcinoma | I | T2N0M0 | |
C03 | F | 42 | Uterus, endometrium | Adenocarcinoma | I | T1N0M0 | |
C04 | F | 65 | Uterus, endometrium | Adenocarcinoma | I | T1N0M0 | |
C05 | F | 53 | Uterus, endometrium | Adenocarcinoma | I~II | T1N0M0 | |
C06 | F | 53 | Uterus, endometrium | Adenocarcinoma | I~II | T1N0M0 | |
C07 | F | 60 | Uterus, endometrium | Adenocarcinoma | I~II | T1N0M0 | |
C08 | F | 53 | Uterus, endometrium | Adenocarcinoma | I~II | T1N0M0 | |
C09 | F | 49 | Uterus, endometrium | Adenocarcinoma | I~II | T1N0M0 | |
C10 | F | 33 | Uterus, endometrium | Adenocarcinoma | I~II | T2N0M0 | |
C11 | F | 60 | Uterus, endometrium | Adenocarcinoma | I~II | T1N0M0 | |
C12 | F | 48 | Uterus, endometrium | Adenocarcinoma | II | T1N0M0 | |
D01 | F | 43 | Uterus, endometrium | Adenocarcinoma | I | T1N0M0 | |
D02 | F | 39 | Uterus, endometrium | Adenocarcinoma | I | T2N0M0 | |
D03 | F | 42 | Uterus, endometrium | Adenocarcinoma | I | T1N0M0 | |
D04 | F | 65 | Uterus, endometrium | Adenocarcinoma | I | T1N0M0 | |
D05 | F | 53 | Uterus, endometrium | Adenocarcinoma | I~II | T1N0M0 | |
D06 | F | 53 | Uterus, endometrium | Adenocarcinoma | I~II | T1N0M0 | |
D07 | F | 60 | Uterus, endometrium | Adenocarcinoma | I~II | T1N0M0 | |
D08 | F | 53 | Uterus, endometrium | Adenocarcinoma | I~II | T1N0M0 | |
D09 | F | 49 | Uterus, endometrium | Adenocarcinoma | I~II | T1N0M0 | |
D10 | F | 33 | Uterus, endometrium | Adenocarcinoma | I~II | T2N0M0 | |
D11 | F | 60 | Uterus, endometrium | Adenocarcinoma | I~II | T1N0M0 | |
D12 | F | 48 | Uterus, endometrium | Adenocarcinoma | II | T1N0M0 | |
E01 | F | 53 | Uterus, endometrium | Adenocarcinoma | II | T2N0M0 | |
E02 | F | 54 | Uterus, endometrium | Adenocarcinoma | II | T1N0M0 | |
E03 | F | 53 | Uterus, endometrium | Adenocarcinoma | II | T1N0M0 | |
E04 | F | 68 | Uterus, endometrium | Adenocarcinoma | II | T1N0M0 | |
E05 | F | 56 | Uterus, endometrium | Adenocarcinoma | II | T2N0M0 | |
E06 | F | 43 | Uterus, endometrium | Adenocarcinoma | II | T1N0M0 | |
E07 | F | 40 | Uterus, endometrium | Adenocarcinoma | II | T2N0M0 | |
E08 | F | 58 | Uterus, endometrium | Adenocarcinoma | II | T1N0M0 | |
E09 | F | 66 | Uterus, endometrium | Adenocarcinoma | II | T2N0M0 | |
E10 | F | 57 | Uterus, endometrium | Adenocarcinoma | II~III | T1N0M0 | |
E11 | F | 43 | Uterus, endometrium | Adenocarcinoma | II~III | T2N0M0 | |
E12 | F | 48 | Uterus, endometrium | Adenocarcinoma | II~III | T1N0M0 | |
F01 | F | 53 | Uterus, endometrium | Adenocarcinoma | II | T2N0M0 | |
F02 | F | 54 | Uterus, endometrium | Adenocarcinoma | II | T1N0M0 | |
F03 | F | 53 | Uterus, endometrium | Adenocarcinoma | II | T1N0M0 | |
F04 | F | 68 | Uterus, endometrium | Adenocarcinoma | II | T1N0M0 | |
F05 | F | 56 | Uterus, endometrium | Adenocarcinoma | II | T2N0M0 | |
F06 | F | 43 | Uterus, endometrium | Adenocarcinoma | II | T1N0M0 | |
F07 | F | 40 | Uterus, endometrium | Adenocarcinoma | II | T2N0M0 | |
F08 | F | 58 | Uterus, endometrium | Adenocarcinoma | II | T1N0M0 | |
F09 | F | 66 | Uterus, endometrium | Adenocarcinoma | II | T2N0M0 | |
F10 | F | 57 | Uterus, endometrium | Adenocarcinoma | II~III | T1N0M0 | |
F11 | F | 43 | Uterus, endometrium | Adenocarcinoma | II~III | T2N0M0 | |
F12 | F | 48 | Uterus, endometrium | Adenocarcinoma | II~III | T1N0M0 | |
G01 | F | 49 | Uterus, endometrium | Adenocarcinoma | II~III | T2N0M0 | |
G02 | F | 53 | Uterus, endometrium | Adenocarcinoma | III | T2N1M0 | |
G03 | F | 53 | Uterus, endometrium | Adenocarcinoma | III | T1N0M0 | |
G04 | F | 51 | Uterus, endometrium | Adenocarcinoma | III | T1N0M0 | |
G05 | F | 46 | Uterus, endometrium | Adenocarcinoma | III | T1N0M0 | |
G06 | F | 53 | Uterus, endometrium | Adenocarcinoma | III | T3N0M0 | |
G07 | F | 67 | Uterus, endometrium | Adenocarcinoma | III | T2N0M0 | |
G08 | F | 52 | Uterus, endometrium | Adenocarcinoma | III | T1N0M0 | |
G09 | F | 60 | Uterus, endometrium | Adenocarcinoma | III | T3N0M0 | |
G10 | F | 36 | Uterus, endometrium | Undifferentiated carcinoma | T1N0M0 | ||
G11 | F | 58 | Uterus, endometrium | Squamous cell carcinoma | II~III | T1N0M0 | |
G12 | F | 44 | Uterus, endometrium | Stromal sarcoma | |||
H01 | F | 49 | Uterus, endometrium | Adenocarcinoma | II~III | T2N0M0 | |
H02 | F | 53 | Uterus, endometrium | Adenocarcinoma | III | T2N1M0 | |
H03 | F | 53 | Uterus, endometrium | Adenocarcinoma | III | T1N0M0 | |
H04 | F | 51 | Uterus, endometrium | Adenocarcinoma | III | T1N0M0 | |
H05 | F | 46 | Uterus, endometrium | Adenocarcinoma | III | T1N0M0 | |
H06 | F | 53 | Uterus, endometrium | Adenocarcinoma | III | T3N0M0 | |
H07 | F | 67 | Uterus, endometrium | Adenocarcinoma | III | T2N0M0 | |
H08 | F | 52 | Uterus, endometrium | Adenocarcinoma | III | T1N0M0 | |
H09 | F | 60 | Uterus, endometrium | Adenocarcinoma | III | T3N0M0 | |
H10 | F | 36 | Uterus, endometrium | Undifferentiated carcinoma | T1N0M0 | ||
H11 | F | 58 | Uterus, endometrium | Squamous cell carcinoma | II~III | T1N0M0 | |
H12 | F | 44 | Uterus, endometrium | Stromal sarcoma | |||
null |
bottom of page